¥7.55   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:949.10万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:7168.08万
52周最高:8.00 52周最低:5.40 转让方式: 单位:美元
$BioNano Genomics(BNGOU)$
  • 还可以输入
  • 20016

BioNano Genomics(BNGOU) 10月08日 10时48分

查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Borodkin Mark
公告日:2018-10-03, 内部交易人:Borodkin Mark, 与发行人关系:Chief Operating Officer/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053866, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053866/0001209191-18-053866-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:BARKER DAVID L
公告日:2018-10-03, 内部交易人:BARKER DAVID L, 与发行人关系:董事/, 操作:买入,3894(股)Common Stock,均价$6.4700; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-21, SEC Accession No. 0001209191-18-053847, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053847/0001209191-18-053847-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Zhou Quan
公告日:2018-10-03, 内部交易人:Zhou Quan, 与发行人关系:董事/10%持股人/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053840, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053840/0001209191-18-053840-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:WANG JUNFENG
公告日:2018-10-03, 内部交易人:WANG JUNFENG, 与发行人关系:董事/10%持股人/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053835, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053835/0001209191-18-053835-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:TWOMEY CHRISTOPHER J
公告日:2018-10-03, 内部交易人:TWOMEY CHRISTOPHER J, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053828, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053828/0001209191-18-053828-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Luderer Albert
公告日:2018-10-03, 内部交易人:Luderer Albert, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053826, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053826/0001209191-18-053826-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Ward Michael James
公告日:2018-10-03, 内部交易人:Ward Michael James, 与发行人关系:Chief Financial Officer/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053817, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053817/0001209191-18-053817-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Robinson Warren
公告日:2018-10-03, 内部交易人:Robinson Warren, 与发行人关系:Chief Commercial Officer/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053811, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053811/0001209191-18-053811-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Holmlin R. Erik
公告日:2018-10-03, 内部交易人:Holmlin R. Erik, 与发行人关系:President and CEO/董事/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053807, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053807/0001209191-18-053807-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Cao Han PHD
公告日:2018-10-03, 内部交易人:Cao Han PHD, 与发行人关系:Chief Scientific Officer/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053806, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053806/0001209191-18-053806-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 10月04日 11时04分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Cai Darren
公告日:2018-10-03, 内部交易人:Cai Darren, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-01, SEC Accession No. 0001209191-18-053805, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118053805/0001209191-18-053805-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 09月21日 21时03分

查看全文

BioNano Genomics(BNGOU) 09月21日 21时03分

查看全文

BioNano Genomics(BNGOU) 09月21日 21时03分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Holmlin R. Erik
公告日:2018-08-27, 内部交易人:Holmlin R. Erik, 与发行人关系:President and CEO/董事/高管/, 操作:买入,1630(股)Common Stock,均价$6.1250; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-23, SEC Accession No. 0001209191-18-048559, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118048559/0001209191-18-048559-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 09月21日 21时03分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Borodkin Mark
公告日:2018-08-27, 内部交易人:Borodkin Mark, 与发行人关系:Chief Operating Officer/高管/, 操作:买入,815(股)Common Stock,均价$6.1250; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-23, SEC Accession No. 0001209191-18-048558, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118048558/0001209191-18-048558-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 09月21日 21时03分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Rosy Shine Ltd
公告日:2018-08-27, 内部交易人:Rosy Shine Ltd, 与发行人关系:10%持股人/, 操作:衍生证券转换(C),199653(股)Common Stock,均价$; 操作:衍生证券转换(C),150550(股)Common Stock,均价$; 操作:衍生证券转换(C),637984(股)Common Stock,均价$; 操作:衍生证券转换(C),784728(股)Common Stock,均价$; 操作:衍生证券转换(C),1134000(股)Common Stock,均价$; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-23, SEC Accession No. 0001209191-18-048557, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118048557/0001209191-18-048557-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 09月21日 21时02分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Zhou Quan
公告日:2018-08-27, 内部交易人:Zhou Quan, 与发行人关系:董事/10%持股人/, 操作:衍生证券转换(C),199653(股)Common Stock,均价$; 操作:衍生证券转换(C),150550(股)Common Stock,均价$; 操作:衍生证券转换(C),637984(股)Common Stock,均价$; 操作:衍生证券转换(C),784728(股)Common Stock,均价$; 操作:衍生证券转换(C),1134000(股)Common Stock,均价$; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-23, SEC Accession No. 0001209191-18-048556, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118048556/0001209191-18-048556-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 09月21日 21时02分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:WANG JUNFENG
公告日:2018-08-27, 内部交易人:WANG JUNFENG, 与发行人关系:董事/10%持股人/, 操作:衍生证券转换(C),199653(股)Common Stock,均价$; 操作:衍生证券转换(C),150550(股)Common Stock,均价$; 操作:衍生证券转换(C),637984(股)Common Stock,均价$; 操作:衍生证券转换(C),784728(股)Common Stock,均价$; 操作:衍生证券转换(C),1134000(股)Common Stock,均价$; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-23, SEC Accession No. 0001209191-18-048555, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118048555/0001209191-18-048555-index.htm $BioNano Genomics(BNGOU)$
查看全文

BioNano Genomics(BNGOU) 09月21日 21时02分

公告 BioNano Genomics, Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Cao Han PHD
公告日:2018-08-27, 内部交易人:Cao Han PHD, 与发行人关系:Chief Scientific Officer/高管/, 操作:衍生证券转换(C),5941(股)Common Stock,均价$; 操作:衍生证券转换(C),1231(股)Common Stock,均价$; 操作:衍生证券转换(C),101918(股)Common Stock,均价$; 操作:衍生证券转换(C),2433(股)Common Stock,均价$; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-23, SEC Accession No. 0001209191-18-048554, File:https://www.sec.gov/Archives/edgar/data/1411690/000120919118048554/0001209191-18-048554-index.htm $BioNano Genomics(BNGOU)$
查看全文
  • 首页 上一页 1 2 3 下一页 尾页  每页20条/共81